January 16, 2013, Sydney, Australia –
(PRWEB) January 16, 2014 -- Steve will be based in the US as part of the IR Americas and Global Leadership Teams and will drive our longstanding relationship with ACI - growing the global strategic alliance. He will continue to develop productive and professional relationships with key personnel to further expand the mutually successful program.
Andre Cuenin, IR President Americas said “We are excited to have such a seasoned and well-connected professional join our team! With the launch of Prognosis 10 for Payments and Infrastructure later this month, Steve will be instrumental in elevating our global alliance with ACI and developing mutual growth opportunities.”
Steve brings to IR a strong payments background having held several executive positions at ACI in both the USA and Asia Pacific, as well as at IBM and BankOne. His deep knowledge and industry expertise in product, sales and marketing positions him well as a leader and driver of success.
IR has a long history of providing the industry’s most innovative solutions to monitor and manage mission critical payment systems. “Now with the release of Prognosis 10 and Business Insight, we are delivering new analytical capabilities to help companies make better business decisions, generate additional revenues and reduce risk. Steve will be working closely with ACI to promote our industry leading solutions in the marketplace,” added Cuenin.
About Integrated Research (IR)
Integrated Research (ASX:IRI) is a leading global provider of proactive performance management software for critical IT infrastructure, payments and communications ecosystems and the creator of award-winning Prognosis®. Organizations in over 50 countries – including some of the world’s largest banks, airlines and telecommunication companies and over 200 of the Fortune 500 companies rely on Prognosis® to ensure continuity-critical systems deliver high availability and performance for millions of their customers across the globe. For further information on Integrated Research and Prognosis®, please visit http://www.ir.com.
t: +61 2 9966 1066